Cindy Tahl, General Counsel and Secretary at FATE THERAPEUTICS INC (FATE), sold 69,800 shares at $115.09 ($8.0M) on 2021-01-19, disclosed to the SEC on 2021-01-21.
Open-market sale of $8.0M FATE by General Counsel and Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $114.11 | 15,835 | $1.8M | 22.6% |
| 2 | $114.11 | 15,835 | $1.8M | 22.6% |
| 3 | $115.09 | 14,944 | $1.7M | 21.5% |
| 4 | $115.09 | 14,944 | $1.7M | 21.5% |
| 5 | $115.97 | 4,021 | $466K | 5.8% |
| 6 | $115.97 | 4,021 |
| $466K |
| 5.8% |
| 7 | $117.07 | 200 | $23K | 0.3% |
| Total | $114.75 avg | 69,800 | $8.0M | 100% |
| Filing → |
| FATE | SELL | 2026-01-12 | $11K | — | Filing → |
| FATE | SELL | 2025-08-05 | $10K | — | Filing → |
| FATE | SELL | 2025-01-13 | $9K | — | Filing → |